Leber's hereditary optic neuropathy (LHON) is associated with mitochondrial DNA (mtDNA) ND mutations that are mostly homoplasmic. However, these mutations are not sufficient to explain the peculiar features of penetrance and the tissue-specific expression of the disease and are believed to be causative in association with unknown environmental or other genetic factors. Discerning between clear-cut pathogenetic variants, such as those that appear to be heteroplasmic, and less penetrant variants, such as the homoplasmic, remains a challenging issue that we have addressed here using next-generation sequencing approach. We set up a protocol to quantify MTND5 heteroplasmy levels in a family in which the proband manifests a LHON phenotype. Furthermore, to study this mtDNA haplotype, we applied the cybridization protocol. The results demonstrate that the mutations are mostly homoplasmic, whereas the suspected heteroplasmic feature of the observed mutations is due to the co-amplification of Nuclear mitochondrial Sequences.
INTRODUCTION
Leber's hereditary optic neuropathy (LHON, MIM#535000), the most common maternally inherited disorder, is characterized by bilateral acute or sub-acute painless loss of central vision and optic atrophy (1) . More than 80% of patients are men, with onset occurring between 8 and 60 years, but in most cases in young adulthood. The classical LHON phenotype is associated with three primary mitochondrial DNA (mtDNA) point mutations, in the MTND1, MTND4 and MTND6 genes encoding for three subunits of mitochondrial respiratory complex I (CI, NADH-ubiquinone oxidoreductase; EC1.6.5.3). Intriguingly, such pathogenic mutations are mostly homoplasmic (2), i.e. identical in hundreds to thousands of copies per cell, according to the concept that homoplasmic neurological-associated mtDNA mutations can generally be considered as having low pathogenicity, with organ-specific phenotypes (3) . Only about one-third of individuals harbouring one of these three mutations eventually develop LHON, and the penetrance varies greatly among different families (4 -6) . It has been proposed that homoplasmic mutations cause diseases with incomplete penetrance in association with other genetic factors, such as mtDNA background (4, 7, 8) , nuclear gene(s) (9) and the co-occurrence of two primary LHON mutations (10) . Even environmental factors are supposed to modulate the phenotypic expression of LHON and the male preponderance in the disease manifestation, due to anatomical, hormonal or physiological factors (11) . Homoplasmic mt-tRNA mutations, which have now been identified in several individuals and families, are considered an exception (12) . In the majority of LHON patients and families, the pathogenic mtDNA mutation is homoplasmic, albeit 14% of the LHON members show the mutation in heteroplasmic condition, a mixture of wild-type and mutant mtDNA (13) . Clinically, there are no differences (14) . The level of heteroplasmy within families may vary extensively among generations and also among offsprings in the same family likely because of a genetic bottleneck effect of mitochondrial distribution occurring in the early stages of oocyte formation (13, (15) (16) (17) (18) . Although the heteroplasmy or the apparent homoplasmy of a mtDNA mutation has been often an overlooked issue, a hot debate has recently sparked on this topic endorsed by the availability of advanced technology to quantify precisely the levels of a mutation even in healthy subjects (19, 20) . In this respect, it becomes increasingly important to define the threshold value of each mutation, primarily for the vast majority of deleterious heteroplasmic or nearlyhomoplasmic mtDNA point mutations responsible for neurological diseases whose mutant load can vary significantly among different tissues, even in the same subject. Considering that cells contain an average of 100 -10 000 mitochondria, and each organelle harbours 2 -10 mtDNA molecules, the number of mtDNA genomes displays a heterogeneous distribution in diverse tissues according to the different energy requirements (21) . Moreover, the fact that a role for nearly-homoplasmic mtDNA mutations may be envisioned in some neurological disease is a scarcely investigated topic.
MTND5, the largest mtDNA-encoded subunit of NADH dehydrogenase, has turned out to be a hotspot for mutations in several mitochondrial pathologies including LHON (22) , mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) (23) , Leigh-like syndrome (24) as well as overlapping mitochondriopathy syndromes (22) . However, most of these mutations have been described as sporadic genetic defects or single clinical cases, and their association with deleterious phenotypes has to be confirmed yet. In addition, the molecular mechanisms of the reported mutations have not been adequately elucidated.
In an attempt to assign a role to low-level heteroplasmy in explaining the different penetrance of LHON, we took advantage from a patient bearing the apparent homoplasmic condition of MTND5 mutations. Low heteroplasmy of residual wild-type molecules has been called into play to explain different phenotypes within a family having comparable levels of heteroplasmy among first-degree relatives, two of whom with no pathologic phenotype, harbouring the same pathogenic (nearly-homoplasmic) MTND5 mutations (23). Here we tested this hypothesis by implementing the deep sampling of the next-generation 454 platform, to detect even a small amount of nucleotide variants in a pool of DNA molecules. The meticulous analysis of high-throughput sequencing data set up in this work led us to conclude that assessment of very low heteroplasmy may determine misinterpretations of complex phenomena such as mitochondrial disease penetrance, if the possibility of the co-amplification of Nuclear mitochondrial Sequences (NumtS) is not envisioned.
RESULTS

Identification of MTND5 m.13528A>G and m.13565C>T mutations in apparent homoplasmy
Upon ruling out the occurrence of primary LHON mutations in the proband by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis, the entire mitochondrial genome was sequenced by applying the Sanger method. The identification of polymorphic sites by mitochondrial haplogroup analysis assigned our proband to haplogroup U4b1b. The proband's genome card obtained by applying the 'Classify your genome' option is available in HmtDB and can be visualized at http://193.204.182.50/files/GenomeCard/ Proband_GenomeCard.html. Among all the observed variants, six non-synonymous homoplasmic mtDNA changes were observed: m.8860A.G (MTATP6 p.T118A), m.13528A.G (MTND5 p.T398A), m.13565C.T (MTND5 p.S410F), m.14766T.C (CYTB p.T7I), m.15326T.C (CYTB p.T194A) and m.15693T.C (CYTB p.M316T). The mutations m.13528A.G and m.13565C.T were analysed in detail because they are already associated with LHON-like disease (25) and to MELAS (23) . In particular, McKenzie et al. (23) reported an almost homoplasmic value of the mutation m.13528A.G in the proband. To test this datum in the family herein described, a PCR-RFLP assay for both MTND5 mutations was set up and performed on total DNA extracted from blood and fibroblasts of the proband (II-2, Fig. 1 ) and from the blood of the proband's mother and sister (I-2 and II-7, respectively). The two MTND5 mutations were detected also in the mother and sister mtDNA in apparent homoplasmy.
Evaluation of bioenergetic competence of cells harbouring the MTND5 mutations
To assess the impact of mutations on oxidative phosphorylation efficiency, mitochondrial competence was determined. The polarographic measurement in digitonin-permeabilized cells showed a significant decrease of CI-dependent respiration (25%; P , 0.05) in the proband-cultured fibroblasts in the presence of NAD-dependent substrates (glutamate plus malate) ( Fig. 2A) . Measurements of oxygen consumption in phosphorylating state were also performed. The respiratory control ratio (RCR), i.e. the ratio between state III and state IV respiration, was reduced by 30% in the proband cells compared with the controls in the presence of glutamate plus malate substrates, indicating CI reduced ability to generate ATP ( Fig. 2A) . No difference in oxygen consumption and RCR index between the proband and control was observed using succinate as a substrate ( Fig. 2A) .
Mitochondrial respiratory redox activity was determined in mitoplasts obtained from fibroblasts. CI activity was significantly lower in the proband compared with control. No difference was observed for the cytochrome c oxidase and adenosine triphosphate (ATP) synthase activity (Fig. 2B) . Moreover, malate, but not succinate, caused a 32% decrease of CV activity (P , 0.05), in the direction of ATP synthesis, suggesting that CI-dependent respiration was not able to synthesize ATP (Fig. 2C) . To evaluate whether the CI dysfunction affected the cellular energetic charge, ATP levels were measured in fibroblasts grown in glucose or in galactose medium (Fig. 2D) . In glucose medium, proband and control cells showed a similar ATP content. By replacing glucose with galactose for 24 h, ATP levels decreased in proband cells by 16% (P , 0.05) compared with cells grown in regular medium (Fig. 2D) ; similar reduction was evident when compared with control cells under the same condition. In control cells, the ATP content was similar under both conditions used. In order to evaluate the production of reactive oxygen species (ROS) in proband fibroblasts, cells were incubated with the intracellular ROS-sensitive fluorescent probe carboxy-H 2 DCFDA. In basal conditions, the intracellular ROS production was double when compared with controls; similarly, although less pronounced, the increase was evident after the addition of tert-butyl hydroperoxide (TBHP), a common inducer of ROS, suggesting that overproduction was possibly due to the alteration of CI function (Supplementary Material, Fig. S1 ).
To assess whether the differences in CI activity of the proband fibroblasts were associated with mtDNA alterations, cybrid cells were used. Transmission of proband mtDNA to the cybrid clones obtained after fusion was confirmed by RFLP and sequencing analysis (data not shown). In five nonpermeabilized cybrid clones, the RCR expressed as ADP/GM was decreased ranging from 30 to 40% in the proband cybrids, indicating a decreased capacity for generating ATP above basal levels; the RCR index of complex II-linked respiration in the proband cybrids was not changed (Fig. 3A) . In digitonin-permeabilized cells, rotenone-sensitive CI-linked respiration was decreased, ranging from 32 to 40% in five clones (mean: 1.1 + 0.2; P , 0.05) of the proband cybrids compared with controls (Fig. 3B) . The CI, CIV and CV activities were measured in mitoplasts obtained from the proband's different cybrid clones. CI activity in the proband clones decreased by 38% compared with control cybrids (P , 0.05) (Fig. 3B) . ATP synthase activity was reduced by 32% (P , 0.001) compared with cybrid controls. No differences were observed when succinate was used as a substrate (Fig. 3C ). This finding indicated that CI ability to generate ATP was decreased. In the proband cybrid clones analysed, we observed no differences in the level of ATP content in regular medium compared with control cybrids. However, when cybrid clones were treated with galactose for 24 h, we detected a reduction in ATP content by 17% (P , 0.001) with respect to the same cells grown in the regular medium (Fig. 3D) ; a similar reduction was evident when compared with control cells under the same condition. In control cybrids, the ATP content was similar under both conditions used.
Assessment of m.13528A>G and m.13565C>T heteroplasmy levels by 454 pyrosequencing
To verify the hypothesis that the incomplete penetrance of disease in the proband's mother and sister was due to heteroplasmic/homoplasmic conditions of the m.13528A.G and m.13565C.T mutations, we used the pyrosequencing protocol by 454 FLX Roche. An average of 2300 reads per sample was sequenced for each of the four samples under study ( Table 1) . The in silico analysis of the entire set of reads was able to pinpoint a clear-cut threshold of similarity equal to 96% which allowed to reveal two clearly distinguishable sets of molecules: the mitochondrial set, with similarity ≥96% with respect to the reference, and the low-similarity set discarded by the alignment program because of a similarity ,96% (Table 1) , mainly composed of co-amplified NumtS. Such reads were associated with the nuclear genome only if their percentage similarity with their best matching NumtS sequence was ≥96%. Reads with a high percentage of 454 sequence errors were discarded because it was not possible to assign them either to mtDNA or to NumtS. Thus, the bioinformatics protocol used allowed us to recognize and to eliminate nuclear co-amplified reads from the real mitochondrial pool, thus excluding 'false heteroplasmy'. Moreover, our data obtained by re-sequencing mtDNA samples of two tissues from the proband and the other family components' blood revealed that the two mutations co-segregated. Indeed, the genotypes observed in all the reads of all the samples were always A/C or G/T (Fig. 4) , although the tiny difference of wild-type total sequencing depth per allele (sdpa; Table 1 ) was due to different coverage per mitochondrial position. In summary, a very low percentage of the A/C wild-type genotype to be assigned to a 'true background heteroplasmy' was observed among the mtDNA-assigned reads and in a more Figure 1 . Family tree. The proband is a 50-year-old man with a diagnosis of optic sub-atrophy indicated by an arrow. He has 4 brothers and 4 sisters, one died at the age of 13 years for chronic renal failure. The healthy mother (I-2) and sister (II-7) gave their signed consent to the present study.
significant fraction [ 1% of mitochondrial reads with quality score (QS) .20] in the fibroblast sample. Comparison with the blood was not feasible due to the physiologically lower mitochondrial copy number present in such a high turnover tissue (21) . Moreover, a Fisher test confirmed the absence of a significant difference between each pair of low-percentage values for the wild-type alleles present in blood samples (P . 0.05). Figure 4 shows how a non-stringent (with a similarity threshold ,96%) multi-alignment of the reads with mtDNA would appear, namely with the presence of different clusters of sequences not only due to mitochondrial molecules, but also to several co-amplified NumtS. To assess the true nature of the reads showing lower similarity with the reference (,96%), sequences were mapped on hg18 by applying BLAST-like alignement tool (BLAT) and by setting on in the UCSC Human Genome browser the RHNumtS tracks. Four nuclear regions were hence recognized, suggesting that nuclear co-amplification was the cause of such a drop in Results are mean + SD from five independent experiments. RCR ¼ state III respiration/state IV respiration. Oxygen consumption was also measured in digitonin-permeabilized cells in control and proband cells with complex II-linked substrate succinate (S) (5 mM, with 5 mg/ml rotenone). Results are mean + SD from five independent experiments. (B) Activities of complexes were measured by spectrophotometry in control and proband fibroblasts. The results are the mean of five independent experiments. Student's t-test analysis:
* P , 0.01. (C) Spectrophotometric determination of complex V activity (ATP synthesis) in fibroblast mitochondria. The activity of the proband's mitochondria was significantly reduced (34%, P , 0.05) compared with the control's mean when M was used as a substrate. No differences were observed with succinate (S). (D) Luminometric measurement of ATP in controls and proband's cultured fibroblasts growth either in the regular medium (Rm) or in the medium supplemented for 24 h with galactose (Gal). In the presence of Gal, the ATP content in proband's fibroblasts was reduced by 20% (P ¼ 0.001) with respect to cells grown in the regular medium. In controls, the ATP content was similar under both conditions. similarity. The NumtS sequences recognized mapped on three different chromosomes: HSA_NumtS_042 on chromosome 1, HSA_NumtS_222 and HSA_NumtS_228 on chromosome 5 and HSA_NumtS_366 on chromosome 10 ( Table 2 ). The presence of the above-mentioned hg18 NumtS in the nuclear DNA of the family members was validated by sequencing, revealing, as in hg18, the presence of A and C in the two nuclear positions aligned to m.13528A and m.13565C of rCRS, with the exception of HSA_NumtS_042, which harboured a deletion in correspondence of the m.13528A position ( Table 2) . To quantify the nuclear co-amplification in each sample, BlastN analysis was performed to identify the reads Figure 3 . Characterization of complex I deficiency and polarographic measurement in control and transmitochondrial cybrids generated with proband mtDNA. (A) Oxygen consumption was measured in digitonin-permeabilized cells in control and proband cells with complex I-linked substrates (5 mM glutamate (G)/5 mM malate (M), rotenone-sensitive fraction). Results are mean + SD from five independent experiments. RCR ¼ state III respiration/state IV respiration. Oxygen consumption was measured in digitonin-permeabilized cells in control and proband cells with complex II-linked substrate succinate (S) (5 mM, with 5 mg/ml rotenone). Results are mean + SD from five independent experiments. (B) Activities of complexes were measured by spectrophotometry in control and proband cybrids. Mitoplasts from five different cybrid clones were spectrophotometrically analysed to measure CI, complex IV and V activities. The results are the mean of five independent experiments. Student's t-test analysis:
* P , 0.05. (C) Spectrophotometric determination of complex V activity (ATP synthesis) in transmitochondrial cybrid mitochondria. The activity of proband's cybrids was significantly reduced (32%, P , 0.01) compared with the control's mean when M was used as a substrate. No differences were observed with succinate (S). (D) Luminometric measurement of ATP in controls and proband's transmitochondrial cybrids growth either in the regular medium (RM) or in the medium supplemented for 24 h with galactose (Gal). In the presence of Gal, the ATP content in proband's cybrids is reduced by 15% (P ¼ 0.001) with respect to same cells grown in regular medium. In controls, the ATP content was similar under both conditions. mapping with high similarity on NumtS sequences (Table 2 ). All four samples showed the presence of a significant number of co-amplified NumtS, ranging from 2.35 to 9.65% (Table 1) . A more robust proof of this sharp nuclear recognition was that the highest similarity found between NumtS sequences and the 361bp-MTND5 reference sequence is below the threshold of 96% used for our analysis, making unlikely a wrong read assignment (Table 2 ).
Variability analysis of patient mitochondrial variants
In order to evaluate a possible role in generating the proband disease phenotype, we have searched in public databases for variability of each non-synonymous mutation. We established that m.8860A, m.14766C and m.15326A are rare rCRS alleles and hence the variants m.8860G, m.14766T and m.15326G are widely present in the world population and neither involved in haplogroup definition nor associated with diseases. m.15693T.C (CYTB p.M316T) contributes to the definition of the U4 haplogroup and hence it is a polymorphic site, located in a highly variable region, when analysed in the multi-alignment of the 'homologene' entry 5013. This site is also at the C-terminus of the conserved domain cytochrome b, thus its variability does not support a role in the definition of a pathologic haplotype. HmtDB query for the m.13528 position yielded 10 genomes, one of which belonging to an Italian proband affected by an endometrial cancer, whereas the remaining were from healthy subjects of different geographical origins. All these genomes were associated with the U4b1b haplogroup. Exactly the same genomes were retrieved when searching for the change m.13565C.T, which indicated a strict co-segregation of the two variants. Indeed m.13528G and m.13565T are two of the 30 variants that define haplogroup U4b1b. Furthermore, a MITOMAP query for both changes allowed to ascertain that they may be prevalently considered as polymorphisms (26, 27) . Moreover, previous studies (25, 28) had assigned a pathogenetic role to the m.13528A.G variant in an LHON-like disease, although with very weak evidence. PolyPhen prediction (29) of pathogenic potential at the protein level revealed the first missense mutation, p.T398A, to be benign, whereas p.S410F to be probably damaging. The interspecies conservation of the two sites was screened via multi-alignment of 11 bilateria MTND5 proteins (Supplementary Material, Fig. S2 ) reported in the homologene entry 36212 (www.ncbi.nlm.nih.gov/homologene). The positions of interest showed high interspecies variability, thus implying no specific functional constraint. This was also confirmed by the data annotated in the Conserved domains database, highlighting that the region where our sites map is external to the conserved domains.
DISCUSSION
The phenotypic expression of primary mtDNA mutations in ND genes is complex and challenging when one intends to address the issue of incomplete penetrance and tissue specificity. We have identified the previously reported MTND5 m.13528A.G and m.13565C.T variants in an LHONaffected individual and in blood samples from his relatives. Both changes were present in apparent homoplasmy in tissues (blood and fibroblasts) analysed from the proband and in the blood of his healthy mother and sister. According to previous reports describing the m.13528A.G mutation as causative but with a strong recessive connotation due to the very high expression threshold, we performed functional and genetic analyses in cell samples derived from the proband and his healthy mother and sister. We found a bioenergetic failure due to complex I deficiency that was evident in the form of a consistent ATP decrease detectable in proband tissues and ROS overproduction in fibroblasts. This decrease was correlated with a significantly reduced ability of the mutant cells to grow in a medium containing galactose instead of glucose, indicating a clear impairment in their oxidative phosphorylation capacity. The deficit was transferred to transmitochondrial cybrids and conclusively demonstrated to be of mtDNA origin. We verified the hypothesis of the incomplete penetrance of disease in the proband's mother and sister as due to heteroplasmic/homoplasmic conditions of either or both MTND5 m.13528A.G and m.13565C.T mutations by exploiting the power of the pyrosequencing protocol. Our findings showed that the two mutations co-segregated and the unexpected presence of most wild-type mtDNA was due to co-amplified NumtS. We excluded a false heteroplasmy that could be measured disregarding the NumtS co-amplification and demonstrated that the very low percentage of the A/C wild-type genotype was observed among the mtDNA-assigned reads and more significantly in the fibroblast sample, according to the higher copy number of mtDNA in fibroblasts than in blood where, instead, NumtS co-amplification is disadvantaged. Our findings do not support those by McKenzie et al.'s (23) who reported an extremely high threshold value of expression (.94%) for the m.13528A.G mutation, thus suggesting that subtle differences in mtDNA mutation loads, as it has been suggested to occur in cancer (30) , may underlie the differential phenotype between the severely affected proband and her clinically healthy mother. These findings, supported by the availability of the RHNumtS compilation (31) and its implementation within the UCSC genome browser as NumtS tracks (32) , have important implications for the investigation of other families with suspected mtDNA disease, and underline the requirement to fulfil strict and established pathogenic criteria in order to avoid misattribution of pathogenicity to mtDNA variants. Four NumtS were co-amplified with mtDNA with different biases. In particular, HSA_NumtS_366 was the most abundant. It is worth noting that the percentage of similarity between any of the four NumtS regions co-amplified and the reference mitochondrial sequence does not exceed the threshold of 96% used for all of the filters applied during the bioinformatic analysis. Given the identity between NumtS alleles and m.13528A and m.13565C, this threshold ruled out from the data 'false wild-type heteroplasmy' that could be quantified looking only at the bases aligned with the two mitochondrial positions in a non-stringent assembly.
a Percentages of similarity were taken from the Blast2Seq output, pinpointing only to the NumtS region mapped on the 361 bp of the mitochondrial reference sequence.
b Reads mapping on each NumtS sequence was done by fixing a minimum similarity threshold of 96%.
Our experiments confirmed a role in generating the proband disease phenotype for these mutations in the context of U4b1b haplogroup as demonstrated by functional studies in cybrids and by the polymorphic nature of the non-synonymous mutations observed in both the proband as well as in the other family samples, although we may not completely rule out the contribution of the nuclear background in determining the bioenergetic failure. Thus, although several evidences showed that the two mutations studied here are polymorphisms, the results reported herein together with previously published data (26, 29) suggest a potential haplogroup background effect of U4b1b. To test this hypothesis, cybrids harbouring mtDNA belonging to the U4 haplogroup family (U4b2, U4b3, U4a, U4c and U4d) and having a close affinity with U4b1b should be generated and functionally tested. Nonetheless, such tests need be the focus of future investigations.
Reports begin to appear where measurements of levels of mutations lead us to the definition of a threshold determining precise phenotypes in terms of bioenergetic competence of cells and other pathological effects (33, 34) . Several studies have shown that the mutated forms of mtDNA are functionally recessive and that a biochemical phenotype is generally associated with high levels of mutation above a crucial threshold in the range 70-90% (35) (36) (37) . Pathologic variants can be considered as recessive until a threshold close to 80%, as it has been recently shown also in tumour cells (34) . Established exceptions are functionally dominant tRNA mutations present at unusually low-level (,25%) in affected tissues (38) .
All available data indicate that mtDNA is constantly subjected to mutational events, with clonal expansion or loss of either point mutations or deletions occurring at random, implying that variants likely occur, albeit at undetectable levels (19) . In this context, homoplasmy at any mtDNA site in normal cells may be the result of technical limitations. Hence, the availability of more sophisticated techniques highlights the concept that homoplasmy may rather be a virtual condition, not only in a single cell, but also among cells, and that the term homoplasmy describes a bona fide state in which co-existing variants are not detectable (19) . In this frame, the hypothesis of whether very low heteroplasmy may truly explain incomplete penetrance of conditions such as LHON, as brought forward several times in substitution for the recognition of other nuclear or mitochondrial modifiers, warrants a thorough revision. The translational significance of extremely low tissue-specific percentages of variants may not be at all biologically relevant as long as most threshold values for phenotypic expression of mtDNA mutations indicate ranges depending on the mutation and cell type starting from 40% (37). Our findings also call for a revision of the pathogenicity criteria for mtDNA variants. Co-segregation of both MTND5 variants here described within the family at comparable levels of heteroplasmy among first-degree relatives, two of whom with no pathologic phenotype, along with the finding that the two changes display a certain degree of variability in the HmtDB database, leaves the question open on whether they may indeed be modifiers rather than causative. Such a consideration arises also from a critical assessment of the use of cybrids to unequivocally prove the exclusive involvement of an mtDNA background in determining a bioenergetic deficit. It must be remembered at all times that although cybrids remain, up to date, the best technology to infer an mtDNA contribution to phenotype, findings may well be complicated by their transformed nuclear background. It has been previously shown, for instance, that the retrograde signalling from organelles to nucleus may trigger completely different responses to mtDNA mutations according to the nuclear background, finally determining the cell fate (39) . In our opinion, all these variables must be taken into account in the attempt of assigning a role to low heteroplasmy to explain incomplete penetrance of mitochondrial diseases.
In conclusion, we cannot explain the different penetrance of the disease in the family members only on a mitochondrial basis and the question of whether these two tightly co-segregating variants may be responsible for the defect remains unresolved. Nevertheless, it is worth noting that our data support the hypothesis that the evaluation of the NumtS presence is of utmost importance in the definition of mtDNA mutation threshold as previously suggested (40, 41) .
MATERIALS AND METHOD
Case report
A 50-year-old man (II-2) was referred to the Ophthalmology Department with a diagnosis of optic sub-atrophy. Since 23 years of age, the patient suffered from IgA mesangial glomerulonephritis. He was the eighth of nine children. His older sister died at the age of 13 from chronic renal failure (II-9). The eldest brother (II-8) and two sisters (II-3 and II-5) are diabetic; a sister (II-7), three brothers (II-1, II-4, II-6) and his mother (I-2) are healthy (Fig. 1) . His healthy father died in an accident at the age of 53. At the age of 44, the proband came to the Ophthalmology Department for a sudden visual impairment at the right eye. He complained of bilateral hearing loss, documented by an audiogram, few months before the examination. His best corrected visual acuity was 20/40 at the right eye and 20/20 at the left eye. Intra-ocular pressure was 12 mmHg bilaterally. Fundus examination showed a hyperaemic and swelling optic disk head in the right eye, whereas the optic nerve head was normal in the left eye. Retinal vessels were slightly congested in both eyes. Computer-guided visual field examination showed a centrocaecal scotoma in the right eye and a global depression of retinal sensitivity in both eyes. Retinal fluorescein angiography showed a normal fluorescence of the optic disk and no staining or leakage of retinal vessels, ruling out a retinal vasculitis. In order to verify the hypothesis of a demyelinating disease, a magnetic resonance imaging of the brain and spinal cord was performed, which resulted negative. Laboratory tests, including a complete screening for infectious diseases, autoimmune disorders (including neuromyelitis opticaimmunoglobulin G), Human Leukocyte Antigens class I and II, were hence performed. Laboratory abnormalities included a slight increase in serum creatinine 1.6 mg/dl (normal range: 0.5-1.1 mg/dl) and blood urea nitrogen 30mg/dl (normal range: 10-20mg/dl) resulting from the IgA mesangial glomerulonephritis. The remaining tests were unremarkable. Steroidal and neurotrophic therapy was administered. The patient was then followed up regularly. After 2 months, the right eye optic disk became sub-atrophic, with a pale appearance, and retinal vessels became normal. At this time, his visual acuity was 20/ 25 (right eye) and 20/20 (left eye).
Instrumental analyses of the proband, performed at this time, showed atrophy of the optical fibres of the right eye. The ocular examination by retinal nerve fibre layer displayed a reduction in the thickness of the fibres in the lower nasal quadrant by optical coherence tomography. The visual evoked potentials of the left eye showed a reduced amplitude and was normal to the right. Neuropsychiatric examinations revealed an obsessive personality. Upon suspicion of a mitochondrial disease, after obtaining informed consent, a skin biopsy aimed at culturing fibroblasts was performed.
Fibroblast and cybrid cell cultures
Human fibroblasts were obtained from skin biopsy and grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% foetal bovine serum (FBS), 4.5g/l glucose and 50mg/ml uridine or in DMEM without glucose and supplemented with 5mM galactose.
Transmitochondrial cybrids were obtained by polyethylene glycol fusion between cytoplasts derived from cytochalasintreated proband fibroblasts with an mtDNA-less (r0) derivative of the human osteosarcoma 143B cell line, followed by selection in a uridine-free medium, as described (42) . Two control cybrid clones containing wild-type mtDNA from different fibroblast cultures were used.
Oxygen consumption rate
The respiratory activity of proband cells with respect to a normal control was measured polarographically with a Clarktype electrode, in an all-glass reaction chamber magnetically stirred, at 378C. Fibroblasts were suspended in Buffer A (75mM sucrose, 50mM KCl, 30mM Tris -Cl, pH 7.4, 2mM KH 2 PO 4 , 2mM MgCl 2 and 10mM ethylene glycol tetraacetic acid). Resting-state respiration was started on the addition of 10mM succinate in the presence of 1mg/ml rotenone or 10mM glutamate and 10mM malate. State III and uncoupled respiration were obtained by adding 0.5mM adenosine diphosphate (ADP) and 0.25mM carbonyl cyanide 3-chlorophenylhydrazone (CCCP). Cell suspension was transferred to the polarographic chamber, and an aliquot was utilized for cell counting with Neubauer chamber. Protein concentration was determined by the Bradford method. Substrates and inhibitors of mitochondrial oxidative phosphorylation (OxPhoS) were added at the following concentrations: 1mg/ml oligomycin, 0.25mM CCCP, 1mg/ml Rotenone, 10mM succinate, 10% digitonin, 1mg/ml antimycin A, 1M ascorbate, 0.1M tetramethylphenylenediamine and 0.1M KCN. Respiration rates are expressed as femtomoles of molecular oxygen per milligram of mitochondrial protein.
Enzymatic spectrophotometric assays
For mitoplast preparation, fibroblasts were harvested with 0.05% trypsin and 0.02% ethylenediaminetetraacetic acid (EDTA) and washed in phosphate buffered saline (PBS), pH 7.4, with 5% FBS. Cells in PBS were incubated 10min on ice with 0.5mg digitonin/mg cellular protein. Mitoplasts were pelleted at 14 000g for 10min and exposed to ultrasound energy for 5s three times at 08C. For NADH-UQ oxidoreductase activity, V max and K m were determined using NADH as electrons donor at 360 -374nm (D1 ¼ 2.01mM 21 cm
21
). Thirty micrograms of sonicated mitoplasts were used in 800ml of buffer (50mM MgCl 2 , pH 7.4, 2mM K-EDTA, 3mM KCN) in the presence of 0.2mM decylubiquinone. The reaction started with different concentrations of NADH (13 -2.8mM). Measurements were determined with and without rotenone 1mg/ml to evaluate only the rotenone-sensitive activity and the V max and K m were calculated by Lineweaver -Burk equation. Cytochrome c oxidase activity was determined in 20mg of sonicated mitoplasts resuspended in 700ml of buffer (10mM phosphate buffer, pH 7.4), following the oxidation of 10mM ferrocytochrome c. The measurement of ATP synthase activity consisted of a coupled double enzymatic assay. Thirty micrograms of sonicated mitoplasts were used in 700ml of 250mM sucrose, 50mM KCl, 5mM MgCl 2 and 20mM Tris -HCl, pH 7.5, in the presence of 2U piruvate kinase, 2.5U lactate dehydrogenase, 1mM phosphoenolpyruvate and 200mM NADH. When 0.5mM ATP was added, NADH oxidation was measured at 340nm. Citrate synthase activity was performed using 30mg/ml of mitoplast, 0.5mM acetyl-coenzyme A and 0.5mM DTNB in 100mM Tris -HCl buffer (pH 8). The reaction was started by the addition of 0.5mM oxalacetate, and the initial rate was measured following the reduction of 5,5
). Citrate synthase activity was used to normalize activities of all respiratory complexes.
ATP synthetase activity
Complex V activity, in the direction of ATP synthesis, was measured in mitochondria derived from proband fibroblasts and from age-matched controls, using spectrophotometric method as previously reported (43) . Briefly, mitochondrial proteins (300mg) were incubated in 20mM Tris-HCl, pH 7.5, 150mM sucrose, 1mM ADP, 20mM phosphate, 5mM MgCl 2 , 100mM diadenosine pentaphosphate, 10mM glucose, 30U hexokinase and either 50mM succinate or 6mM malate, at 378C in vials with vigorous stirring to ensure maximal oxygenation. The reaction was started by the addition of the substrate and stopped with 25mM EDTA and 2mM CCCP, followed by transfer to ice-cold water. The synthesized glucose 6-phosphate was oxidized by NADP in the presence of 30U glucose 6-phosphatedehydrogenase. NADPH formation was monitored at 340nm.
Cellular ATP content
Cellular ATP content was assayed luminometrically using 2 × 10 4 cells by the ATPLITE 1 STEP (Perkin Elmer, Boston, MA, USA) according to the procedure recommended by the manufacturer. For this experiment, three different controls were used in 16 different experiments, either in regular medium and in galactose-supplemented medium. For proband, the experiments were run four times in the regular medium and in the galactose-supplemented medium. For either sample, each experiment was run four times at the same moment.
Determination of ROS production
Intracellular ROS production was measured using the 5-(and-6)-carboxy-2 ′ ,7 ′ -dichlorodihydrofluorescein diacetate probe (carboxy-H 2 DCFDA) (I36007 kit; Molecular Probes, Eugene, OR, USA). Briefly, 2 × 10 4 fibroblasts were plated and left to attach for 7h, then growth medium was removed and replaced with 6mM carboxy-H 2 DCFDA in PBS-Ca 2+ Mg
2+
, either in the absence or presence of TBHP. Plates were incubated for 20min at 378C, 5% CO 2 . After DCF removal, ROS production was monitored for 20min in a 1420 Victor2 (Perkin Elmer Life Science, USA) at l ex 485 nm and l em 520 nm. Three different control fibroblast cultures were used in two different experiments. For each sample, each experiment was run three times at the same moment.
PCR-RFLP analysis for MTND5 mutations
The presence of the m.13528A.G mutation (p.T398A) was confirmed by PCR amplification, followed by Fnu4HI restriction enzyme digestion. A mismatched PCR was designed to screen for the m.13565C.T mutation (p.S410F), in which a restriction site for MseI was introduced in the presence of T at position m.13565. The presence of the mutations was confirmed on mtDNA extracted from the proband's fibroblasts and the mother and the sister blood (II-7, Fig. 1 ).
Library manufacturing and 454 pyrosequencing
The 454 pyrosequencing estimation of mutant load at positions m.13528 and m.13565 on rCRS required a preparation of 361 bp long tagged amplicons from the four DNA samples (Table 1 ) mixed in a library to be sequenced by 454 technology with a depth of about 2000× per sample (44) . Supplementary Material, Table S1 reports the tagged primers used to prepare the amplicons. The library was checked using a highsensitivity kit of miniaturized capillary gel electrophoresis (Agilent 2100 Bioanalyzer; Agilent, Santa Clara, CA, USA), diluted and amplified in emulsion PCR on beads, using GS FLX Titanium SV emPCR Kit (Lib-L) and loaded into the 454 GS-FLX plate (Roche, Basel, Switzerland). Fastq files were extracted from the Standard Flowgram File (SFF) produced by the 454 software and sorted out to each of the four samples as previously described (44) .
Bioinformatics processing of 454 pyrosequencing data
The mapping of the reads was performed using as reference the sequence obtained from the proband's peripheral blood matching with 361 bp of MTND5 (m.13325 -m.13685 on rCRS). This sequence, used as reference in all the pairwise alignments performed in this work, carried the two mutations: m.13528A.G and m.13565C.T. Reads, assigned to each sample by applying TagFinder as previously described (44) , were pairwise aligned with the reference sequence and then collapsed in a reference-guided assembly with MOSAIK (v.1.0.138) (http://bioinformatics.bc.edu/marthlab/Mosaik), setting a maximum percentage of mismatches (mmp) ¼ 4%, a hashing size (hs) ¼ 11, an alignment candidate threshold (act) ¼ 12 and the 'unique' alignment mode (m). The mmp threshold was fixed considering the 454 system rate of error per read reported by Margulies et al. (45) . This parameter allowed to discard reads showing similarity lower than 96% with the reference mitochondrial sequence. SAM tools were used to store the MOSAIK reference-guided assemblies in a 'pileup format' for the accurate analysis of the two mitochondrial sites under study (46) . Single-position analyses were performed using the 'NGS: SAM tools', available from the UCSC Genome Browser Galaxy suite (http://main.g2.bx.psu.edu/). Each of the four pileup files were filtered, considering only a QS per position ≥20 and the sdpa was calculated both on the forward and reverse reads carrying the mutation. Samples were considered heteroplasmic if they presented an mtDNA variant at ≥1% of the total coverage of the mitochondrial position. Reads filtered by MOSAIK because of a similarity with the reference ,96% were analysed by applying BLAT (47) versus the complete reference human genome assembly hg18 available on the UCSC Genome Browser. Here, the NumtSeq tracks (32) based on the RHNumtS compilation were activated in the effort to verify a suspected NumtS co-amplification (31) . BlastN was used with the default parameters, except for the e-value ¼ 0.001, to search for the best match between reads discarded by MOSAIK and a local database composed by the human NumtS, downloaded from UCSC and the reference mitochondrial sequence, added to check the real absence of any mitochondrial sequence in the pool. BlastN results were filtered twice, first for the 'bit score' value and then for a similarity match ≥96% with NumtS. Primer-Blast (http://www.ncbi.nlm.nih.gov/tools/p rimer-blast) was used to design pairs of primers external/internal to the identified NumtS, according to the protocol described in Lascaro et al. (31) , in order to validate their co-amplification in all the family members. To verify the specificity of each primer, both the 5 ′ and 3 ′ primers and the MTND5 region were 'blatted' versus hg18. Supplementary Material, Figure S3 displays the example of the primer pair used for the specific NumtS whose RHNumtS Identifier is HSA_NumtS_288.
Statistical analyses
Data are presented as absolute numbers, mean with standard deviation or percentages. Results are analysed with Student's t-test. A P-value ,0.05 was considered statistically significant. Fisher's exact test (a ¼ 0.05) was used to compare couple of total sdpa values (sdpa on forward + sdpa on reverse strand) for the same allele.
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